Sentences with phrase «genentech over the drug»

VanderBeek and his colleagues» findings come after years of tension between eye doctors and Avastin's maker Genentech over the drug's ophthalmic use.

Not exact matches

But, says Michael Varney, head of the small molecule drug discovery group at Genentech, those hiring trends are about to change: «For us, over the next 3 years, we'll hire more medicinal chemists and more process and scale - up chemists than we will analytical chemists.»